A citation-based method for searching scientific literature

Daneng Li, Nienke A de Glas, Arti Hurria. Clin Geriatr Med 2016
Times Cited: 18







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Frailty in older adults: evidence for a phenotype.
L P Fried, C M Tangen, J Walston, A B Newman, C Hirsch, J Gottdiener, T Seeman, R Tracy, W J Kop, G Burke,[...]. J Gerontol A Biol Sci Med Sci 2001
27


Geriatric assessment-identified deficits in older cancer patients with normal performance status.
Trevor A Jolly, Allison M Deal, Kirsten A Nyrop, Grant R Williams, Mackenzi Pergolotti, William A Wood, Shani M Alston, Brittaney-Belle E Gordon, Samara A Dixon, Susan G Moore,[...]. Oncologist 2015
111
16

Future of cancer incidence in the United States: burdens upon an aging, changing nation.
Benjamin D Smith, Grace L Smith, Arti Hurria, Gabriel N Hortobagyi, Thomas A Buchholz. J Clin Oncol 2009
16

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
16

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
A Serpa Neto, M Tobias-Machado, M A P Esteves, M D Senra, M L Wroclawski, F L A Fonseca, R B Dos Reis, A C L Pompeo, A D Giglio. Prostate Cancer Prostatic Dis 2012
52
11

Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.
Kathryn Bylow, William Dale, Karen Mustian, Walter M Stadler, Miriam Rodin, William Hall, Mark Lachs, Supriya G Mohile. Urology 2008
98
11

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†.
L Decoster, K Van Puyvelde, S Mohile, U Wedding, U Basso, G Colloca, S Rostoft, J Overcash, H Wildiers, C Steer,[...]. Ann Oncol 2015
357
11

Conceptualisation and measurement of frailty in elderly people.
K Rockwood, D B Hogan, C MacKnight. Drugs Aging 2000
174
11

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
11

Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.
Janet S de Moor, Angela B Mariotto, Carla Parry, Catherine M Alfano, Lynne Padgett, Erin E Kent, Laura Forsythe, Steve Scoppa, Mark Hachey, Julia H Rowland. Cancer Epidemiol Biomarkers Prev 2013
421
11

Personalizing medicine in geriatric oncology.
Christine M Walko, Howard L McLeod. J Clin Oncol 2014
24
11

Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.
Arti Hurria, Constance T Cirrincione, Hyman B Muss, Alice B Kornblith, William Barry, Andrew S Artz, Linda Schmieder, Rafat Ansari, William P Tew, Douglas Weckstein,[...]. J Clin Oncol 2011
224
11

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).
Laura Biganzoli, Hans Wildiers, Catherine Oakman, Lorenza Marotti, Sibylle Loibl, Ian Kunkler, Malcolm Reed, Stefano Ciatto, Adri C Voogd, Etienne Brain,[...]. Lancet Oncol 2012
346
11

Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.
Willemien van de Water, Esther Bastiaannet, Elysée T M Hille, Elma M Meershoek-Klein Kranenbarg, Hein Putter, Caroline M Seynaeve, Robert Paridaens, Anton J M de Craen, Rudi G J Westendorp, Gerrit-Jan Liefers,[...]. Oncologist 2012
31
11

External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.
Willemien van de Water, Mandy Kiderlen, Esther Bastiaannet, Sabine Siesling, Rudi G J Westendorp, Cornelis J H van de Velde, Johan W R Nortier, Caroline Seynaeve, Anton J M de Craen, Gerrit-Jan Liefers. J Natl Cancer Inst 2014
47
11

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.
Karen Barnett, Stewart W Mercer, Michael Norbury, Graham Watt, Sally Wyke, Bruce Guthrie. Lancet 2012
11

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014
802
11

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Cornelis J H van de Velde, Daniel Rea, Caroline Seynaeve, Hein Putter, Annette Hasenburg, Jean-Michel Vannetzel, Robert Paridaens, Christos Markopoulos, Yasuo Hozumi, Elysee T M Hille,[...]. Lancet 2011
236
11

Common cancers in the elderly.
J Hansen. Drugs Aging 1998
29
11


Prognostic indices for older adults: a systematic review.
Lindsey C Yourman, Sei J Lee, Mara A Schonberg, Eric W Widera, Alexander K Smith. JAMA 2012
460
11

Cancer survivorship and cancer rehabilitation: revitalizing the link.
Catherine M Alfano, Patricia A Ganz, Julia H Rowland, Erin E Hahn. J Clin Oncol 2012
96
11

Activities, function, and health-related quality of life (HRQOL) of older adults with cancer.
Mackenzi Pergolotti, Allison M Deal, Grant R Williams, Ashley L Bryant, Jeannette T Bensen, Hyman B Muss, Bryce B Reeve. J Geriatr Oncol 2017
49
11

Cancer Immunotherapy in Older Patients.
Kristen A Marrone, Patrick M Forde. Cancer J 2017
12
16

Immune system, cell senescence, aging and longevity--inflamm-aging reappraised.
Stefano Salvioli, Daniela Monti, Catia Lanzarini, Maria Conte, Chiara Pirazzini, Maria Giulia Bacalini, Paolo Garagnani, Cristina Giuliani, Elisa Fontanesi, Rita Ostan,[...]. Curr Pharm Des 2013
111
11

Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions.
Arti Hurria, Lee Jones, Hyman B Muss. Am Soc Clin Oncol Educ Book 2016
41
11


Inflammaging and human longevity in the omics era.
Daniela Monti, Rita Ostan, Vincenzo Borelli, Gastone Castellani, Claudio Franceschi. Mech Ageing Dev 2017
74
11

Geriatric oncology: how far have we gone and what are the next steps?
Jean-Emmanuel Kurtz, Damien Heitz, Valérie Kurtz-Illig, Patrick Dufour. Oncology 2009
10
20

Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals.
Silvia Giovannini, Graziano Onder, Rosa Liperoti, Andrea Russo, Christy Carter, Ettore Capoluongo, Marco Pahor, Roberto Bernabei, Francesco Landi. J Am Geriatr Soc 2011
107
11

Biology of cancer and aging: a complex association with cellular senescence.
Claire Falandry, Marc Bonnefoy, Gilles Freyer, Eric Gilson. J Clin Oncol 2014
74
11

Alterations of the systemic environment are the primary cause of impaired B and T lymphopoiesis in telomere-dysfunctional mice.
Zhangfa Song, Jianwei Wang, Luis Miguel Guachalla, Grzegorz Terszowski, Hans-Reimer Rodewald, Zhenyu Ju, K Lenhard Rudolph. Blood 2010
41
11


Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.
Gregory T Armstrong, Toana Kawashima, Wendy Leisenring, Kayla Stratton, Marilyn Stovall, Melissa M Hudson, Charles A Sklar, Leslie L Robison, Kevin C Oeffinger. J Clin Oncol 2014
288
11

Cancer treatment and survivorship statistics, 2016.
Kimberly D Miller, Rebecca L Siegel, Chun Chieh Lin, Angela B Mariotto, Joan L Kramer, Julia H Rowland, Kevin D Stein, Rick Alteri, Ahmedin Jemal. CA Cancer J Clin 2016
11

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
Supriya G Mohile, William Dale, Mark R Somerfield, Mara A Schonberg, Cynthia M Boyd, Peggy S Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M Holmes, Judith O Hopkins,[...]. J Clin Oncol 2018
415
11

Geroscience: linking aging to chronic disease.
Brian K Kennedy, Shelley L Berger, Anne Brunet, Judith Campisi, Ana Maria Cuervo, Elissa S Epel, Claudio Franceschi, Gordon J Lithgow, Richard I Morimoto, Jeffrey E Pessin,[...]. Cell 2014
834
11

The hallmarks of aging.
Carlos López-Otín, Maria A Blasco, Linda Partridge, Manuel Serrano, Guido Kroemer. Cell 2013
11

The integration of inflammaging in age-related diseases.
Tamas Fulop, Jacek M Witkowski, Fabiola Olivieri, Anis Larbi. Semin Immunol 2018
109
11

Radical prostatectomy or watchful waiting in early prostate cancer.
Anna Bill-Axelson, Lars Holmberg, Hans Garmo, Jennifer R Rider, Kimmo Taari, Christer Busch, Stig Nordling, Michael Häggman, Swen-Olof Andersson, Anders Spångberg,[...]. N Engl J Med 2014
600
5

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
Eric J Small, Paul F Schellhammer, Celestia S Higano, Charles H Redfern, John J Nemunaitis, Frank H Valone, Suleman S Verjee, Lori A Jones, Robert M Hershberg. J Clin Oncol 2006
799
5

Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
Leon Sun, Arthur A Caire, Cary N Robertson, Daniel J George, Thomas J Polascik, Kelly E Maloney, Philip J Walther, Danielle A Stackhouse, Benjamin D Lack, David M Albala,[...]. J Urol 2009
69
5


Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Johann Sebastian de Bono, Stephane Oudard, Mustafa Ozguroglu, Steinbjørn Hansen, Jean-Pascal Machiels, Ivo Kocak, Gwenaëlle Gravis, Istvan Bodrogi, Mary J Mackenzie, Liji Shen,[...]. Lancet 2010
5

Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Gjermund Henriksen, Knut Breistøl, Øyvind S Bruland, Øystein Fodstad, Roy H Larsen. Cancer Res 2002
193
5

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
M J Zelefsky, K E Wallner, C C Ling, A Raben, T Hollister, T Wolfe, A Grann, P Gaudin, Z Fuks, S A Leibel. J Clin Oncol 1999
237
5

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, Primo N Lara, Jeffrey A Jones, Mary Ellen Taplin, Patrick A Burch, Donna Berry, Carol Moinpour, Manish Kohli,[...]. N Engl J Med 2004
5

Duration of androgen suppression in the treatment of prostate cancer.
Michel Bolla, Theodorus M de Reijke, Geertjan Van Tienhoven, Alphonsus C M Van den Bergh, Jorg Oddens, Philip M P Poortmans, Eliahu Gez, Paul Kil, Atif Akdas, Guy Soete,[...]. N Engl J Med 2009
640
5

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
Gerhardt Attard, Alison H M Reid, Timothy A Yap, Florence Raynaud, Mitch Dowsett, Sarah Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd,[...]. J Clin Oncol 2008
657
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.